Company news

Vivos Therapeutics, Inc. news in 2023

Vivos Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

November 28, 2023

Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea

November 28, 2023

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

November 13, 2023

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

November 8, 2023

Vivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare

November 2, 2023

Vivos Therapeutics Closes $4 Million Private Placement

November 1, 2023

Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

October 30, 2023

Vivos Therapeutics Announces Reverse Stock Split

October 25, 2023

Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

October 23, 2023

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

October 10, 2023

Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion

October 4, 2023

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

October 3, 2023

Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call

August 15, 2023

Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call

August 13, 2023

Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call

August 9, 2023

Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update

June 7, 2023

Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call

June 5, 2023

Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations

May 8, 2023

Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational Update

March 29, 2023

Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, LLC

February 28, 2023

Vivos Therapeutics Regains Compliance with Nasdaq Listing Requirements

January 19, 2023

Vivos Therapeutics Closes $8 Million Private Placement

January 8, 2023

Vivos Therapeutics Announces Pricing of $8 Million Private Placement

January 4, 2023

Vivos Therapeutics Receives FDA 510(k) Clearance of its Flagship DNA Oral Appliance for Treatment of Obstructive Sleep Apnea

January 3, 2023

Calls in 2023